Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 392 of 1,261
  1. US 10799525

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  2. US 10800833

    Co-stimulatory domains for use in genetically-modified cells

    Precision BioSciences, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  3. US 10799461

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  4. US 10800810

    Active peptide for inhibiting AMPA receptor and preparation method and use thereof

    CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  5. US 10800853

    Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

    VACCINEX, INC. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  6. US 10800797

    Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same

    The Regents of the University of California · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  7. US 10800850

    Therapeutic antibodies

    CytomX Therapeutics, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  8. US 10801030

    General secretory pathway (GSP) mutant listeria SPP., and methods for making and using the same

    The Regents of the University of California · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  9. US 10800855

    Chimeric cytokine receptors and encoding nucleic acids

    AUTOLUS LIMITED · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  10. US 10801076

    Influenza A virus variants

    Vertex Pharmaceuticals Incorporated · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  11. US 10799092

    System and method for cleansing segments of a luminal network

    Covidien LP · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  12. US 10799561

    Method for increasing cardiac inflow by administering a compound that binds RXFP1

    Relaxera Pharmazeutische Gesellschaft mbH & Co. KG · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  13. US 10799514

    Non-hormonal steroid modulators of NF-kappa beta for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  14. US 10799511

    Methods for reducing or ameliorating mortality and/or morbidity due to chlorine inhalation

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  15. US 10799512

    Estrogen combination for treatment of multiple sclerosis

    The Regents of the University of California · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  16. US 10799520

    Lipotechoic acid for immune modulation

    Northwestern University · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  17. US 10799490

    Pharmaceutical compositions of therapeutically active compounds

    Agios Pharmaceuticals, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  18. US 10800781

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  19. US 10799472

    Antiparasitic compositions and methods

    TYRATECH, INC. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  20. US 10799466

    Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief

    The Board of Regents of the University of Texas System · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  21. US 10799475

    Substituted phenyl aziridine precursor analogs for inhibiting androgen-independent prostate cancer cell growth

    Northwestern University · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  22. US 10799535

    Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  23. US 10798955

    Compositions of particulate coformulation

    Nektar Therapeutics · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  24. US 10799549

    Hepatoprotective traditional chinese medicine composition containing fructus ligustri lucidi, herba exliptae, radix paeoniae alba, rhizoma curcumae longae and clam extract, preparation method and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.